| Phenton Travis Harker, MD | |
|
250 Pleasant St, Crfhc, Concord, NH 03301-7539 | |
| (603) 228-7200 | |
| (603) 228-7307 |
| Full Name | Phenton Travis Harker |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 250 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629148911 | NPI | - | NPPES |
| 4491080 | Other | NH | CIGNA INSURANCE |
| 4152065 | Other | NH | MVP INSURANCE |
| 3375424 | Other | NH | AETNA INSURANCE |
| 30206388 | Medicaid | NH | |
| AA75724 | Other | NH | HARVARD PILGRIM INSURANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 13320 (New Hampshire) | Primary |
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 13320 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cornerstone Vna | Rochester, NH | Home health agency |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appledore Medical Group Inc | 5698666154 | 89 |
News Archive
A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno(R) (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study demonstrating a major role of the unique carbohydrate complex Bimuno against neuro-inflammation and anxiety.
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.
Experts from key EU projects united in Brussels at Nanomedicine in Europe today to deliver a strong message to the European Parliament that concerted and coordinated action is needed to ensure the widespread benefits offered by advances in nanomedicine are not squandered.
› Verified 2 days ago
| Entity Name | Appledore Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720077167 PECOS PAC ID: 5698666154 Enrollment ID: O20040601000165 |
News Archive
A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno(R) (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study demonstrating a major role of the unique carbohydrate complex Bimuno against neuro-inflammation and anxiety.
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.
Experts from key EU projects united in Brussels at Nanomedicine in Europe today to deliver a strong message to the European Parliament that concerted and coordinated action is needed to ensure the widespread benefits offered by advances in nanomedicine are not squandered.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phenton Travis Harker, MD 250 Pleasant St, Crfhc, Concord, NH 03301-7539 Ph: (603) 228-7200 | Phenton Travis Harker, MD 250 Pleasant St, Crfhc, Concord, NH 03301-7539 Ph: (603) 228-7200 |
News Archive
A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno(R) (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study demonstrating a major role of the unique carbohydrate complex Bimuno against neuro-inflammation and anxiety.
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.
Experts from key EU projects united in Brussels at Nanomedicine in Europe today to deliver a strong message to the European Parliament that concerted and coordinated action is needed to ensure the widespread benefits offered by advances in nanomedicine are not squandered.
› Verified 2 days ago
Amy E Kershaw, P.T. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Pillsbury St, Concord, NH 03301 Phone: 615-778-4066 | |
Dr. Doris H Lotz, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 129 Pleasant St, Office Medicaid Business And Policy, Concord, NH 03301 Phone: 603-271-9422 | |
Duane Allan Dietz, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste G100, Concord, NH 03301 Phone: 603-230-1970 Fax: 603-227-7573 |